Blog Tag
3 articles tagged with Commercialization. The newest post is from Mar 4, 2026.
Label expansion is when an already approved drug gains approval for a new use, a broader population, a different age group, or another disease setting. In biotech, label expansion matters because it can extend the commercial life of a product and unlock new revenue opportunities without needing to build a brand-new drug from scratch.
An exclusivity period is a time during which a drug is protected from certain forms of competition after approval. In biotech, exclusivity matters because it gives the company time to commercialize the product without immediate copycat competition. That protection is one of the key reasons innovative drugs can generate meaningful revenue after launch.
In biotech, an indication is the specific disease or condition a drug is approved or being developed to treat. It tells the market what the medicine is for and helps define the size and economics of the opportunity. Indication matters because a drug’s value depends heavily on how broad or narrow the approved use is.
